MiSUD Locator
Provider Map of Substance Use Disorder Services and Programs in the State of Michigan...
Apr 15th 2025
Equity and Harm Reduction for Communities of Color
To achieve equity, we must focus special efforts on reducing harms related to substance use in communities of color that are disproportionately impacted. It is important to strive to expose...
Oct 27th 2022
Oct 28th 2022
Jama Publication: Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions
A retrospective observational study supporting the investment of ED MOUD – results based on California specific data...
Apr 15th 2025
Critical Updates About the X-Waiver Removal
CA Bridge provides updates and next steps now that the X-Waiver requirement has been removed...
Oct 27th 2022
Removal of DATA Waiver (X-Waiver) Requirement
Details from SAMHSA regarding the removal of the DATA Waiver (X-Waiver) requirement...
Oct 28th 2022
An Effective Treatment for Opioid Addiction
The article highlights the effectiveness of buprenorphine as a treatment for opioid use disorder in an emergency medicine setting and the challenges that patients face in accessing it....
Apr 15th 2025
MAT Toolkit for Nurses
A patient-centered approach to 24/7 access to medication for addiction treatment. This toolkit covers the basics of managing the care of a patient with opioid use disorder (OUD) in the...
Oct 27th 2022
Clinical Opioid Withdrawal Scale
Clinical Opioid Withdrawal Score (COWS) can help ensure the patient is ready for the first dose of buprenorphine. This tool can be used in both inpatient and outpatient settings to...
Oct 28th 2022
Medicines for Treating Opioid Use Disorder: What you Need to Know
Medicines for Treating Opioid Use Disorder: Buprenorphine, Methadone, Naltrexone, No Medication...
Oct 27th 2022